May 4, 2018 - Update on Phase III IMMU - 132 TNBC trial. 176 study locations with new additions now recruiting:
University of Chicago Medical Center 5841 S. Maryland Ave
[Recruiting]
Chicago, Illinois, United States, 60637
Contact: Simona Olberkyte 773-834-2756 rnanda@medicine.bsd.uchicago.edu
University of Chicago Comprehensive Cancer Center at Silver Cross Hospital 1900 Silver Cross Blvd
[Recruiting]
New Lenox, Illinois, United States, 60451
Contact: Simona Olberkyte 773-834-9774 solberkyte@medicine.bsd.uchicago.edu
Orland Park - UCMC Center for Advanced Care 14290 South LaGrange Rd
[Recruiting]
Orland Park, Illinois, United States, 60462
Contact: Simona Olberkyte 773-834-9774 solberkyte@medicine.bsd.uchicago.edu
Mayo, 200 First Street SW
[Recruiting]
Rochester, Minnesota, United States, 55905
Contact: Jean Jensen 507-288-1115 jensen.jean@mayo.edu
Vanderbilt Breast Cancer Center at One Hundred Oaks 719 Thompson Lane, Suite 25000
[Recruiting]
Nashville, Tennessee, United States, 37204
Contact: Tammy Lewis-Burgan 615-936-3618 tammy.l.lewis-burgan@vanderbilt.edu
Henry-Joyce Cancer Clinic 1301 Medical Center Drive 1903 The Vanderbilt Clinic Nashville, TN 37232
[Recruiting]
Nashville, Tennessee, United States, 37232
Contact: Tammy Lewis-Burgan 615-936-3618 tammy.l.lewis-burgan@vanderbilt.edu
|
